353 related articles for article (PubMed ID: 27556947)
1. Structural basis for inhibition of a voltage-gated Ca
Tang L; Gamal El-Din TM; Swanson TM; Pryde DC; Scheuer T; Zheng N; Catterall WA
Nature; 2016 Sep; 537(7618):117-121. PubMed ID: 27556947
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Diltiazem Block of a Voltage-Gated Ca
Tang L; Gamal El-Din TM; Lenaeus MJ; Zheng N; Catterall WA
Mol Pharmacol; 2019 Oct; 96(4):485-492. PubMed ID: 31391290
[TBL] [Abstract][Full Text] [Related]
3. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for Ca2+ selectivity of a voltage-gated calcium channel.
Tang L; Gamal El-Din TM; Payandeh J; Martinez GQ; Heard TM; Scheuer T; Zheng N; Catterall WA
Nature; 2014 Jan; 505(7481):56-61. PubMed ID: 24270805
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for efonidipine block of a voltage-gated Ca
Xu F; Xiong W; Huang Y; Shen J; Zhou D; Tang L
Biochem Biophys Res Commun; 2019 Jun; 513(3):631-634. PubMed ID: 30981510
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of drug binding and action on L-type calcium channels.
Hockerman GH; Peterson BZ; Johnson BD; Catterall WA
Annu Rev Pharmacol Toxicol; 1997; 37():361-96. PubMed ID: 9131258
[TBL] [Abstract][Full Text] [Related]
7. Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca
Zhao Y; Huang G; Wu J; Wu Q; Gao S; Yan Z; Lei J; Yan N
Cell; 2019 May; 177(6):1495-1506.e12. PubMed ID: 31150622
[TBL] [Abstract][Full Text] [Related]
8. Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.
Lin M; Aladejebi O; Hockerman GH
Eur J Pharmacol; 2011 Nov; 670(1):105-13. PubMed ID: 21910984
[TBL] [Abstract][Full Text] [Related]
9. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels.
Huber IG; Wappl-Kornherr E; Sinnegger-Brauns MJ; Hoda JC; Walter-Bastl D; Striessnig J
J Biol Chem; 2004 Dec; 279(53):55211-7. PubMed ID: 15504730
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of 1,4-dihydropyridines with ion channels].
Veizerová L; Svetlík J; Kettmann V
Ceska Slov Farm; 2008 Apr; 57(2):58-62. PubMed ID: 18578414
[TBL] [Abstract][Full Text] [Related]
12. Phenylalkylamines in calcium channels: computational analysis of experimental structures.
Tikhonov DB; Lin L; Yang DSC; Yuchi Z; Zhorov BS
J Comput Aided Mol Des; 2020 Nov; 34(11):1157-1169. PubMed ID: 32648151
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca
Gao S; Yan N
Angew Chem Int Ed Engl; 2021 Feb; 60(6):3131-3137. PubMed ID: 33125829
[TBL] [Abstract][Full Text] [Related]
14. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
15. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.
Langs DA; Strong PD; Triggle DJ
J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783
[TBL] [Abstract][Full Text] [Related]
16. Evidence of human-like Ca
Baig AM; Rana Z; Waliani N; Karim S; Rajabali M
Chem Biol Drug Des; 2019 Mar; 93(3):351-363. PubMed ID: 30362253
[TBL] [Abstract][Full Text] [Related]
17. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
Noll G; Lüscher TF
Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
[TBL] [Abstract][Full Text] [Related]
19. Receptor pharmacology of calcium entry blocking agents.
Vaghy PL; Williams JS; Schwartz A
Am J Cardiol; 1987 Jan; 59(2):9A-17A. PubMed ID: 2433927
[TBL] [Abstract][Full Text] [Related]
20. 1,4-Dihydropyridines as calcium channel ligands and privileged structures.
Triggle DJ
Cell Mol Neurobiol; 2003 Jun; 23(3):293-303. PubMed ID: 12825828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
